Skip to Content

AMNEAL 806 (Temozolomide 250 mg)

Pill with imprint AMNEAL 806 is White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by Amneal Pharmaceuticals.

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AMNEAL 806

Temozolomide 250 mg AMNEAL 806
Temozolomide 250 mg AMNEAL 806
Temozolomide 250 mg AMNEAL 806

Temozolomide

Imprint
AMNEAL 806
Strength
250 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals
National Drug Code (NDC)
65162-0806

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.